Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Hemophilia A and B can have similar symptoms, but their underlying causes and potential treatments differ.
The JNC, celebrating its 22nd year, hosts children and teens in the bleeding disorders community for a weekend full of sports…
Tim Grams, father of four, dove into swimming as a young person and today stays active despite Hemophilia A.
CSL recognizes patients around the globe who live with bleeding disorders such as hemophilia. Continued innovation and improv…
Clotting factors are proteins in blood plasma that prevent excessive bleeding. They’re essential to the cascade of events cal…
Most physical therapists at Hemophilia Treatment Centers are using research-based best practices to help patients decrease pa…
Patients might see a hematologist if they have a bleeding disorder, anemia, sickle cell disease, leukemia or other conditions…
The Chicago-area event begins April 28 and offers hematology fellows a chance to connect and learn about benign hematology.
Watch a short video about the patient journey, including gene therapy.
Eke and Sterre talk about life with hemophilia, a bleeding disorder mostly associated with men. They’re advocating for more a…
Earlier this month, CSL hosted a weekend of baseball, basketball, golf and swimming for kids in the bleeding disorders commun…
The National Hemophilia Foundation changed its name and officially broadened its mission to include all bleeding disorders. G…
Americas
Asia Pacific
Middle East
Europe
